• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.14% Nasdaq Down 0.04%

    Alkermes plc (ALKS)

    -NasdaqGS
    55.74 Down 0.24(0.43%) Jan 23, 4:00PM EST
    Prev Close:55.98
    Open:55.94
    Bid:49.52 x 1300
    Ask:N/A
    1y Target Est:64.25
    Beta:2.00921
    Earnings Date:Feb 23 - Feb 27 (Est.)
    Day's Range:55.04 - 56.50
    52wk Range:27.14 - 60.74
    Volume:465,604
    Avg Vol (3m):970,576
    Market Cap:8.47B
    P/E (ttm):N/A
    EPS (ttm):-1.70
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ALKS

    Comparison

    Symbol% ChgMkt Cap
    ALKSDown 0.43%8.47B
    LLYDown 0.64%80.07B
    GSKUp 0.52%96.95B
    ABTDown 0.30%69.63B

    Key Statistics

    Forward P/E (1 yr):163.94
    P/S (ttm):12.24
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-16) :-0.20
    Quarterly EPS Est (Dec-16) :0.04
    Mean Recommendation*:2.3
    PEG Ratio (5 yr expected):9.81

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products that are designed to address unmet medical needs of patients in various therapeutic areas worldwide. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback